[Venetoclax with low-dose cytarabine for patients with untreated acute myeloid leukemia ineligible for intensive chemotherapy: results from the Chinese cohort of a phase three randomized placebo-controlled trial].
Zhonghua Xue Ye Xue Za Zhi
; 42(4): 288-294, 2021 Apr 14.
Article
in Zh
| MEDLINE
| ID: mdl-33979972
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Leukemia, Myeloid, Acute
/
Cytarabine
Type of study:
Clinical_trials
/
Risk_factors_studies
Limits:
Adult
/
Aged
/
Humans
Country/Region as subject:
Asia
Language:
Zh
Journal:
Zhonghua Xue Ye Xue Za Zhi
Year:
2021
Document type:
Article
Affiliation country: